Dr. Bryan Liu - CAR-T Therapy & Cellular Immunotherapy Specialist | CancerCareE
Dr. Bryan Liu - CAR-T Therapy and Cellular Immunotherapy Specialist
Leading CAR-T Therapy Specialist

Dr. Bryan Liu

Director of International Department, Tianjin Cancer Hospital Airport Hospital

Leading specialist in CAR-T therapy, cellular immunotherapy and gene therapy with over 10 years of clinical experience in treating complex hematologic malignancies including refractory and relapsed leukemia, lymphoma, and multiple myeloma.

CAR-T Therapy Cellular Immunotherapy Gene Therapy Hematologic Malignancies Leukemia Lymphoma Multiple Myeloma

Working Experience

  • Director of the International Department, Tianjin Cancer Hospital Airport Hospital
  • Member of the Ethics Committee at Tianjin Cancer Hospital Airport Hospital
  • Founder of Bioocus Medical Group & CGT Centers
  • Professor of Scientific Research Management at the School of Life Sciences, Beijing Institute of Technology
  • Leader of the Party Working Group of the Cellular Immunotherapy Professional Committee at the China Association for the Promotion of Human Health Technology

Areas of Expertise

  • Proficient in chemotherapy, targeted therapy, CAR-T therapy, and immunotherapy for hematologic malignancies
  • Extensive clinical experience with malignant hematologic conditions such as refractory and relapsed leukemia, lymphoma, and multiple myeloma
  • Adept at managing complex and challenging cases
  • Achieved significant breakthroughs in treating recurrent cases using cellular immunotherapy for international patients
  • Serves as an immunotherapy consultant for Apollo Hospitals in India, fostering cross-border medical collaboration

Clinical Experience

Over 10 Years of Clinical Experience

Specializing in the diagnosis and treatment of complex hematological diseases

300+ Cellular Immunotherapy Cases

Participated in more than 300 cases of cellular immunotherapy for international patients

Broad Treatment Experience

Extensive experience treating recurrent leukemia, lymphoma, Neuroblastoma, multiple myeloma, MG, SLE, SSC, Thalassemia, SCD, TDT

Areas of Scientific Research

  • Devoted to cellular immunotherapy and gene therapy for two decades
  • Achieved significant results in CAR-T therapy, TILs therapy, NK therapy, and gene therapy
  • Founded 4 Cellular and Gene therapy centers (CGT centers) in Beijing and Tianjin

Consult with Dr. Bryan Liu

Get expert advice on CAR-T therapy, cellular immunotherapy and gene therapy for hematologic malignancies

Request Online Evaluation